{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:02:39Z","timestamp":1788321759893,"version":"build-2803163510"},"reference-count":37,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T00:00:00Z","timestamp":1481241600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T00:00:00Z","timestamp":1481241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"funder":[{"DOI":"10.13039\/501100005032","name":"Funda\u00e7\u00e3o Bial","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Esteve"},{"DOI":"10.13039\/100007343","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1111\/ane.12720","type":"journal-article","created":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T14:05:28Z","timestamp":1481292328000},"page":"254-264","source":"Crossref","is-referenced-by-count":14,"title":["EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure"],"prefix":"10.1155","volume":"136","author":[{"given":"V.","family":"Villanueva","sequence":"first","affiliation":[{"name":"Hospital Universitario y Polit\u00e9cnico La Fe; Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bermejo","sequence":"additional","affiliation":[{"name":"Hospital Universitario Puerta Hierro; Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Montoya","sequence":"additional","affiliation":[{"name":"Hospital Lluis Alcanyis; X\u00e1tiva Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Toledo","sequence":"additional","affiliation":[{"name":"Hospital Universitario Vall d\u2032Hebron; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"G\u00f3mez-Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[{"name":"Hospital Universitario y Polit\u00e9cnico La Fe; Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Garc\u00e9s","sequence":"additional","affiliation":[{"name":"Hospital Universitario y Polit\u00e9cnico La Fe; Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vilella","sequence":"additional","affiliation":[{"name":"Hospital Universitario Vall d\u2032Hebron; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. J.","family":"L\u00f3pez-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Hospital Clinico Universitario; Santiago Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Rodriguez-Osorio","sequence":"additional","affiliation":[{"name":"Hospital Clinico Universitario; Santiago Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Campos","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednico Universitario; Valladolid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Hospital Universitario Virgen del Rocio; Sevilla Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Giner","sequence":"additional","affiliation":[{"name":"Hospital Universitario Dr. Peset; Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Zurita","sequence":"additional","affiliation":[{"name":"Hospital Universitario Infanta Leonor; Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Rodr\u00edguez-Uranga","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Sagrado Coraz\u00f3n; Instituto de Especialidades Neurol\u00f3gicas; Sevilla Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ojeda","sequence":"additional","affiliation":[{"name":"Hospital Universitario Infanta Sof\u00eda; Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Mauri","sequence":"additional","affiliation":[{"name":"Hospital Clinico Universitario Lozano Blesa; Zaragoza Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Camacho","sequence":"additional","affiliation":[{"name":"Hospital Clinico Universitario Lozano Blesa; Zaragoza Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ruiz-Gim\u00e9nez","sequence":"additional","affiliation":[{"name":"Hospital Universitario Virgen de las Nieves; Granada Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Poza","sequence":"additional","affiliation":[{"name":"Hospital Universitario Donosti; San Sebastian Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Massot-Tarr\u00fas","sequence":"additional","affiliation":[{"name":"Hospital Universitario Gregorio Mara\u00f1on; Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Galiano","sequence":"additional","affiliation":[{"name":"Hospital Universitario Gregorio Mara\u00f1on; Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bonet","sequence":"additional","affiliation":[{"name":"Hospital Arnau de Vilanova; Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,12,9]]},"reference":[{"key":"10.1111\/ane.12720-BIB0001|ane12720-cit-0001","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.yebeh.2013.05.038","article-title":"Alternative monotherapy or add-on therapy in patients with epilepsy whose seizures do not respond to the first monotherapy: an Italian multicenter prospective observational study","volume":"28","author":"Millul","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.12720-BIB0002|ane12720-cit-0002","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1684\/epd.2014.0650","article-title":"Early add-on treatment vs alternative monotherapy in patients with partial epilepsy","volume":"16","author":"Semah","year":"2014","journal-title":"Epileptic Disord"},{"issue":"Suppl 1","key":"10.1111\/ane.12720-BIB0003|ane12720-cit-0003","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/epi.12494","article-title":"Medical management of refractory epilepsy: practical treatment with novel antiepileptic drugs","volume":"55","author":"Ben-Menachem","year":"2014","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12720-BIB0004|ane12720-cit-0004","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1212\/01.wnl.0000286959.22040.6e","article-title":"Quantifying the response to antiepileptic drugs: effect of past treatment history","volume":"70","author":"Schiller","year":"2008","journal-title":"Neurology"},{"key":"10.1111\/ane.12720-BIB0005|ane12720-cit-0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.phrs.2016.03.003","article-title":"Addressing the burden of epilepsy: many unmet needs","volume":"107","author":"Beghi","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1111\/ane.12720-BIB0006|ane12720-cit-0006","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1111\/j.1528-1167.2007.01222.x","article-title":"Psychiatric comorbidity in epilepsy: a population-based analysis","volume":"48","author":"Tellez-Zenteno","year":"2007","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12720-BIB0007|ane12720-cit-0007","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.eplepsyres.2014.06.002","article-title":"Self-rated and assessed cognitive functions in epilepsy: impact on quality of life","volume":"108","author":"Giovagnoli","year":"2014","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12720-BIB0008|ane12720-cit-0008","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1684\/epd.2014.0714","article-title":"Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs","volume":"16","author":"Zaccara","year":"2014","journal-title":"Epileptic Disord"},{"key":"10.1111\/ane.12720-BIB0009|ane12720-cit-0009","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.yebeh.2008.09.027","article-title":"Quality of life in seizure-free patients with epilepsy on monotherapy","volume":"14","author":"Auriel","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.12720-BIB0010|ane12720-cit-0010","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1525-5050(02)00037-9","article-title":"The relationship between poor medication compliance and seizures","volume":"3","author":"Cramer","year":"2002","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.12720-BIB0011|ane12720-cit-0011","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.eplepsyres.2015.03.007","article-title":"Treatment non-adherence as a trigger for status epilepticus: an observational, retrospective study based on therapeutic drug monitoring","volume":"113","author":"Lie","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12720-BIB0012|ane12720-cit-0012","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1528-1167.2008.01794.x","article-title":"Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study","volume":"50","author":"Faught","year":"2009","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12720-BIB0013|ane12720-cit-0013","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1212\/WNL.0000000000001023","article-title":"Antiepileptic drug nonadherence predicts pediatric epilepsy seizure outcomes","volume":"83","author":"Modi","year":"2014","journal-title":"Neurology"},{"key":"10.1111\/ane.12720-BIB0014|ane12720-cit-0014","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.yebeh.2015.01.035","article-title":"Economic evaluation of a behavior-modifying intervention to enhance antiepileptic drug adherence","volume":"45","author":"Plumpton","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.12720-BIB0015|ane12720-cit-0015","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1528-1167.2008.01946.x","article-title":"Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study","volume":"50","author":"Elger","year":"2009","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12720-BIB0016|ane12720-cit-0016","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0404.2009.01218.x","article-title":"Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures","volume":"120","author":"Gil-Nagel","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12720-BIB0017|ane12720-cit-0017","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.eplepsyres.2010.01.014","article-title":"Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy","volume":"89","author":"Ben-Menachem","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12720-BIB0018|ane12720-cit-0018","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12883-015-0305-5","article-title":"Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a historical-control phase III study","volume":"15","author":"Jacobson","year":"2015","journal-title":"BMC Neurol"},{"key":"10.1111\/ane.12720-BIB0019|ane12720-cit-0019","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/epi.12934","article-title":"Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a randomized historical-control phase III study based in North America","volume":"56","author":"Sperling","year":"2015","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12720-BIB0020|ane12720-cit-0020","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1212\/WNL.0000000000002497","article-title":"Conversion to eslicarbazepine acetate monotherapy: a pooled analysis of 2 phase III studies","volume":"86","author":"Sperling","year":"2016","journal-title":"Neurology"},{"key":"10.1111\/ane.12720-BIB0021|ane12720-cit-0021","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.nurt.2006.10.005","article-title":"Eslicarbazepine acetate (BIA 2-093)","volume":"4","author":"Almeida","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1111\/ane.12720-BIB0022|ane12720-cit-0022","doi-asserted-by":"crossref","first-page":"e00124","DOI":"10.1002\/prp2.124","article-title":"Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action","volume":"3","author":"Soares-Da-silva","year":"2015","journal-title":"Pharmacol Res Perspect"},{"key":"10.1111\/ane.12720-BIB0023|ane12720-cit-0023","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s00115-010-3177-3","article-title":"Abrupt switch from extended-release oxcarbazepine to eslicarbazepine acetate [German]","volume":"82","author":"Steinhoff","year":"2011","journal-title":"Nervenarzt"},{"key":"10.1111\/ane.12720-BIB0024|ane12720-cit-0024","first-page":"309","article-title":"Eslicarbazepine acetate in clinical practice. Efficacy and safety results [Spanish]","volume":"56","author":"Serrano-Castro","year":"2013","journal-title":"Rev Neurol"},{"key":"10.1111\/ane.12720-BIB0025|ane12720-cit-0025","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.eplepsyres.2014.06.017","article-title":"Two-year follow-up with eslicarbazepine acetate: a consecutive, retrospective, observational study","volume":"108","author":"Correia","year":"2014","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12720-BIB0026|ane12720-cit-0026","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.nrl.2013.02.013","article-title":"Post-authorisation study of eslicarbazepine as treatment for drug-resistant epilepsy: preliminary results","volume":"29","author":"Massot","year":"2014","journal-title":"Neurologia"},{"key":"10.1111\/ane.12720-BIB0027|ane12720-cit-0027","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.eplepsyres.2014.04.014","article-title":"Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: results of the 1-year ESLIBASE retrospective study","volume":"108","author":"Villanueva","year":"2014","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12720-BIB0028|ane12720-cit-0028","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/ane.12574","article-title":"Real-world data on eslicarbazepine acetate as add-on to antiepileptic monotherapy","volume":"134","author":"Holtkamp","year":"2016","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12720-BIB0029|ane12720-cit-0029","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures","volume":"22","author":"Commission","year":"1981","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12720-BIB0030|ane12720-cit-0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eplepsyres.2005.05.005","article-title":"Effectiveness of lamotrigine in clinical practice: results of a retrospective population-based study","volume":"65","author":"Knoester","year":"2005","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12720-BIB0031|ane12720-cit-0031","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1528-1167.2012.03605.x","article-title":"Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Integrated analysis of pooled data from double-blind phase III clinical studies","volume":"54","author":"Gil-Nagel","year":"2013","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12720-BIB0032|ane12720-cit-0032","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40261-014-0255-5","article-title":"Early add-on lacosamide in a real-life setting: results of the REALLY study","volume":"35","author":"Villanueva","year":"2015","journal-title":"Clin Drug Investig"},{"key":"10.1111\/ane.12720-BIB0033|ane12720-cit-0033","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/epi.13224","article-title":"A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: the VITOBA study","volume":"56","author":"Runge","year":"2015","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12720-BIB0034|ane12720-cit-0034","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1212\/WNL.0000000000002791","article-title":"Nonadherence to antiepileptic drugs in Germany: a retrospective, population-based study","volume":"87","author":"Gollwitzer","year":"2016","journal-title":"Neurology"},{"key":"10.1111\/ane.12720-BIB0035|ane12720-cit-0035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.eplepsyres.2015.06.013","article-title":"Assessing long-term effects of eslicarbazepine acetate on lipid metabolism profile, sodium values and liver function tests","volume":"115","author":"Ley","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12720-BIB0036|ane12720-cit-0036","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.yebeh.2015.05.036","article-title":"Practical guidance and considerations for transitioning patients from oxcarbazepine or carbamazepine to eslicarbazepine acetate-expert opinion","volume":"50","author":"Peltola","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.12720-BIB0037|ane12720-cit-0037","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/ane.12645","article-title":"Overnight switching from oxcarbazepine to eslicarbazepine acetate: an observational study","volume":"135","author":"Schmid","year":"2017","journal-title":"Acta Neurol Scand"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12720","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12720","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12720\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T03:13:36Z","timestamp":1718939616000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,9]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.12720","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12,9]]}}}